Curaleaf Holdings Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Matt Darin

Chief Executive Officer (CEO)

US$5.2m

Compensación total

Porcentaje del salario del CEO	14.5%
Permanencia del CEO	2yrs
Participación del CEO	0.6%
Permanencia media de la dirección	3.3yrs
Promedio de permanencia en la Junta Directiva	4.9yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Matt Darin en comparación con los beneficios de Curaleaf Holdings?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-US$237m
Dec 31 2023	US$5m	US$750k	-US$230m
Sep 30 2023	n/a	n/a	-US$343m
Jun 30 2023	n/a	n/a	-US$312m
Mar 31 2023	n/a	n/a	-US$268m
Dec 31 2022	US$5m	US$683k	-US$258m
Sep 30 2022	n/a	n/a	-US$157m
Jun 30 2022	n/a	n/a	-US$202m
Mar 31 2022	n/a	n/a	-US$223m
Dec 31 2021	US$2m	US$350k	-US$206m

Compensación vs. Mercado: La compensación total ($USD5.18M) de Matt está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD6.72M).

Compensación vs. Ingresos: La compensación de Matt ha aumentado mientras la empresa no es rentable.

CEO

Matt Darin

2yrs

Permanencia

US$5,181,965

Compensación

Mr. Matthew S. Darin, also known as Matt, serves as President and Director at Curaleaf, Inc. He served as President of Curaleaf Holdings, Inc since January 04, 2022 until May 09, 2022 and serves as Chief E...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Boris Jordan	Executive Chairman	5.6yrs	US$12.35m	4.93% $ 190.6m
Matthew Darin	Chief Executive Officer	2yrs	US$5.18m	0.58% $ 22.4m
Joseph Lusardi	Executive Vice-Chairman	5.6yrs	US$1.23m	0.72% $ 27.6m
Edward Kremer	Chief Financial Officer	1.8yrs	US$2.76m	0.027% $ 1.0m
Peter Clateman	Chief Legal Officer	4.2yrs	US$1.39m	0.11% $ 4.1m
Camilo Lyon	Chief Investment Officer	1.8yrs	sin datos	sin datos
Jakob Feinstein	Manager of Investor Relations	no data	sin datos	sin datos
James Shorris	Chief Compliance Officer	4.2yrs	sin datos	sin datos
Tracy Brady	Senior Vice President of Corporate Communications	4.4yrs	sin datos	sin datos
Kate Lynch	Executive Vice President of Marketing	3.3yrs	sin datos	sin datos
Tyneeha Rivers	Chief People Officer	2yrs	sin datos	sin datos
Jessie Kater	Senior Vice President of Innovation	no data	sin datos	sin datos

3.3yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CURL.F se considera experimentado (3.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Boris Jordan	Executive Chairman	5.6yrs	US$12.35m	4.93% $ 190.6m
Joseph Lusardi	Executive Vice-Chairman	5.6yrs	US$1.23m	0.72% $ 27.6m
Mitchell Kahn	Director	3.8yrs	US$250.00k	0.51% $ 19.8m
Peter Derby	Independent Director	5.6yrs	US$350.00k	0.069% $ 2.7m
Karl Johansson	Independent Director	5.6yrs	US$350.00k	0.013% $ 500.3k
Robert Schnoll	Member of the Medical Advisory Board	no data	sin datos	sin datos
Jaswinder Grover	Independent Director	4.3yrs	US$250.00k	0.75% $ 28.8m
Michelle Bodner	Director	1.4yrs	US$250.00k	0.033% $ 1.3m
Shasheen Shah	Independent Director	1.4yrs	US$250.00k	0.0028% $ 108.2k

4.9yrs

Permanencia media

59.5yo

Promedio de edad

Junta con experiencia: La junta directiva de CURL.F se considera experimentada (4.8 años de antigüedad promedio).

Curaleaf Holdings Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Curaleaf Holdings, Inc., Annual General Meeting, Jun 14, 2024

Curaleaf Holdings, Inc., Annual General Meeting, Oct 04, 2023

Curaleaf Holdings, Inc., Annual General Meeting, Sep 08, 2022

Curaleaf Holdings, Inc. Announces Management Appointments

Curaleaf Holdings, Inc. Announces Executive Changes

Curaleaf Holdings, Inc., Annual General Meeting, Jun 23, 2022

Recent updates

Curaleaf Holdings, Inc. (TSX:CURA) completed the acquisition of Northern Green Canada Inc. (NGC).

Curaleaf Holdings, Inc., Annual General Meeting, Jun 14, 2024

Curaleaf Holdings, Inc. to Report Q1, 2024 Results on May 09, 2024

Curaleaf Holdings, Inc. (TSX:CURA) signed a deal to acquire Northern Green Canada Inc. (NGC).

Curaleaf Expands Zero Proof™ Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix

Curaleaf Holdings, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Curaleaf Holdings, Inc. has completed a Follow-on Equity Offering in the amount of CAD 16.2 million.

Curaleaf Expands Brand Portfolio with Launch of Zero Proof ™ Cannabis-Infused Drinkables

Curaleaf Holdings, Inc., Annual General Meeting, Oct 04, 2023

Curaleaf Holdings, Inc.'s Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

Curaleaf Holdings, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Curaleaf Holdings, Inc. Unveils Strategic National Rebrand of Select

Curaleaf Holdings, Inc. Announces Closure of Operations in California, Colorado and Oregon

Curaleaf Holdings, Inc. Announces Expansion of BlueKudu Infused Chocolate Flavors Available on Florida Retail Menus

Curaleaf Holdings, Inc. Announces the Launch of Adult-Use Sales At Its Bordentown, New Jersey Location

Curaleaf Holdings Relocates Deerfield, IL Dispensary and Opens Doors to Adult-Use Customers

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) completed the acquisition of Tryke Companies, LLC for approximately $180 million.

Curaleaf Holdings, Inc., Annual General Meeting, Sep 08, 2022

Curaleaf Holdings, Inc. Announces Management Appointments

Curaleaf Holdings, Inc. Launches Plant Precision, New Product Line Targeting Specific Health and Wellness Categories

Curaleaf Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Curaleaf Expands New Jersey Adult-Use Sales to Edgewater Park Dispensary

Curaleaf Expands New Jersey Adult-Use Sales to Edgewater Park Dispensary

Curaleaf Holdings, Inc. Reports Impairment Loss for the Quarter Ended March 21, 2022

Curaleaf Holdings, Inc. Announces Executive Changes

Curaleaf Holdings, Inc Expands Product Offerings With Launch of BlueKudu Chocolates in Florida

Curaleaf Holdings, Inc., Annual General Meeting, Jun 23, 2022

Curaleaf Holdings, Inc. Announces its Select Brand Launches Limited-Edition Cliq Elite Live Strain in California

Curaleaf Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Curaleaf Holdings, Inc. Reports Impairment of Intangible Assets for the Fourth Quarter Ended December 31, 2021

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of Bloom Dispensaries.

Curaleaf Holdings, Inc. (CNSX:CURA) entered into a definitive agreement to acquire Bloom Dispensaries for approximately $210 million.

Curaleaf Holdings, Inc. (CNSX:CURA) agreed to acquire Natural Remedy Patient Center, LLC for $13 million.

Curaleaf Holdings, Inc. announced that it has received $475 million in funding

Curaleaf Holdings, Inc. Launches Select X Bites

Curaleaf Holdings, Inc. Announces the Release of Cliq by Select

Curaleaf Holdings, Inc. (CNSX:CURA) signed definitive documents to acquire Los Sueños Farms LLC for $75 million.

Curaleaf Holdings, Inc. Provides Revenue Guidance for the Second Quarter of 2021

PharmaCann Inc. acquired Elevate Takoma dispensary from Curaleaf Holdings, Inc. (CNSX:CURA).

Curaleaf Holdings, Inc. Completes Reorganization of its Maryland Business

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of Maryland Compassionate Care and Wellness LLC.

Curaleaf Holdings, Inc. announced that it has received $130 million in funding

Curaleaf Holdings, Inc. Appoints Carlos Madrazo as Senior Vice President Investor Relations and Capital Markets

Curaleaf Holdings, Inc. (CNSX:CURA) signed a definitive agreement to acquire Emmac Life Sciences Limited for approximately £250 million.

Curaleaf Holdings, Inc. to Report Q4, 2020 Results on Mar 09, 2021

Curaleaf Holdings, Inc. has completed a Follow-on Equity Offering in the amount of CAD 275.55 million.

Curaleaf Holdings, Inc. announced that it has received CAD 50 million in funding

Curaleaf Holdings, Inc. Launches Fast Onset Nano Chews in Florida

Curaleaf Holdings, Inc. Announces Joseph Lusardi to Be Named Executive Vice-Chairman

Curaleaf Holdings, Inc. Announces Executive Changes

TerrAscend Corp. (CNSX:TER) signed a definitive agreement to acquire HMS Health, LLC and HMS Processing, LLC from Curaleaf Holdings, Inc. (CNSX:CURA) for $27.5 million.

Curaleaf Holdings, Inc. Announces Launch of Collection of Vape Cartridges

Curaleaf Holdings, Inc. Expands Product Line Featuring Fast Acting Nanoemulsion Technology with NANO Drops

Curaleaf Holdings, Inc. to Report Q3, 2020 Results on Nov 17, 2020

Curaleaf Holdings, Inc. (CNSX:CURA) acquired Verdure, Inc.

Curaleaf Holdings, Inc.'s Select Brand Announces Partnership with Jim Belushi and Belushi's Farm

Curaleaf Holdings, Inc. (CNSX:CURA) acquired 18% stake in Blackjack Collective from minority owners for $1.3 million.

Curaleaf Holdings, Inc. Launches Select Nano Gummies in California and its Line of Select Elite Live Cartridges in Nevada

Curaleaf Holdings, Inc. Appoints Talley Wettlaufer as Senior Vice President of Retail

Freehold Properties, Inc completed the acquisition of six properties located in Florida, Massachusetts and New Jersey from Curaleaf Holdings, Inc. (CNSX:CURA).

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of three dispensaries of Arrow Alternative Care in Connecticut.

Curaleaf Holdings, Inc. announced that it has received CAD 27.500003 million in funding

Curaleaf Holdings, Inc. to Report Q2, 2020 Results on Aug 17, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media